Melitus sp. z o.o. Report issue

For profit Phase 2
Founded: Warsaw Poland (2007)

Organization Overview

First Clinical Trial
2018
NCT03887208
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Melitus Ltd | Melitus sp. z o.o.

Active Ingredients

Drugs in Phase 2 Trials (1)

autologous adipose-derived mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cicatrix (Phase 2)

Cutis Laxa (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1